Insider Trading & Executive Data
Start Free Trial
41 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
Agilon Health is a value-based care operator that partners with community primary care physician groups through long-term professional service agreements and local risk-bearing entities (RBEs) to manage Medicare Advantage and Medicare FFS populations under global capitation and ACO arrangements. The company provides a technology and clinical platform (CORE, HCC Manager, Minerva), data/analytics, capital and operational support, and shares savings with physician partners; membership grew rapidly in 2024 (526,500 MA members) but has since softened into 2025 (~497,500). Revenue and membership trends are highly sensitive to CMS policy, MA bidding/benchmarks, risk-adjustment outcomes, payor contracting and required risk capital, and the business carries concentrated partner and regulatory risk.
Given agilon’s model and the MD&A disclosures, executive pay is likely focused on growth and operating metrics that drive capitation economics: MA membership growth, PMPM medical margin (medical margin in absolute dollars and PMPM), risk-adjustment accuracy, quality/ACO shared-savings metrics, and adjusted EBITDA or cash runway. Long-term incentives (stock awards/RSUs and multi-year performance vesting) are appropriate because the company signs very long professional service agreements (typical 20-year terms) and needs to align executives with partner retention and multi-year margin improvement; the filings explicitly show stock‑based compensation is a material line item and was reduced in 2024. Compensation committees will also weigh liquidity and capital-raise risk (term/revolver maturities, letters of credit and capital commitments), so supplemental pay or retention awards tied to successful payor renewals, CMS performance thresholds (HEDIS/Star/ACO savings), and capital preservation milestones are plausible. Finally, intense regulatory oversight (CMS/OIG/DOJ, Stark/AKS, False Claims) and the sensitivity of revenue to actuarial and reserve judgments mean compensation plans often include clawbacks, compliance gating and discretionary adjustments for regulatory or settlement outcomes.
Material nonpublic information at agilon is frequently tied to membership counts, payor contract renewals/terminations, CMS risk-adjustment data and MA bid/benchmark changes, timing of payor settlements and ACO/shared‑savings determinations, and liquidity/capital-raising plans — all events that can sharply move revenue and margins. Expect routine trading blackouts around monthly/quarterly enrollment and CMS bid windows, earnings releases, and known payor settlement periods; insider sales may also reflect personal liquidity needs driven by equity vesting rather than negative signal, given SBP was a notable expense reduction in 2024. Because the company may need additional capital and relies on letters of credit/credit facilities, watch insider activity before equity or debt raises as a potential signal of management views on valuation or financing necessity. Finally, compliance risk is elevated in this industry, so structured trading programs (10b5-1) and formal pre-clearance are likely used to avoid appearance of trading on sensitive health plan or CMS data.